Special Drug Use Investigation for LAMICTAL Bipolar

Trial Profile

Special Drug Use Investigation for LAMICTAL Bipolar

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Aug 2017

At a glance

  • Drugs Lamotrigine (Primary)
  • Indications Bipolar disorders
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 15 Aug 2017 Primary endpoint (Time to recurrence/relapse of mood episodes in patients) has been met, as per results published in the Journal of Clinical Psychiatry.
    • 15 Aug 2017 Results (n=966) published in the Journal of Clinical Psychiatry.
    • 21 Apr 2016 Status changed from not yet recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top